OPTION CARE HEALTH, INC. financials

  1. Home
  2. Financials
  3. OPCH
OPCH CIK 0001014739

Source: EDGAR filings · Built 2026-06-02T03:45:01Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 217.14M 287.79M 329.43M 232.19M 182.94M 100.52M
EBITDA 405.44M 382.74M 373.80M 300.80M 253.90M 182.06M
Working Capital 435.62M 542.48M 475.95M 428.99M 250.56M 222.99M
Net Debt 1.04B 805.41M 822.56M 860.84M 1.04B 1.11B
Gross Margin 19.26% 20.27% 22.81% 22.41% 22.67% 22.50%
Operating Margin 5.98% 6.44% 7.31% 6.21% 5.55% 3.65%
Net Margin 3.67% 4.24% 6.21% 3.89% 4.07% -0.27%
Return on Equity (ROE) 15.65% 15.08% 18.79% 10.86% 11.90% -0.80%
Return on Assets (ROA) 6.01% 6.19% 8.30% 4.84% 5.01% -0.30%
Current Ratio 1.53× 1.70× 1.77× 1.76× 1.55× 1.51×
Debt-to-Equity 0.96× 0.87× 0.82× 0.83× 0.99× 1.20×
Effective Tax Rate 26.62% 25.31% 25.55% 26.83% -20.09% -54.03%
Cash Conversion Ratio 1.25× 1.53× 1.39× 1.78× 1.49× -15.77×
Accruals Ratio -0.01× -0.03× -0.03× -0.04× -0.02× -0.05×
SBC % of Revenue 0.71% 0.72% 0.71% 0.43% 0.28% 0.10%
CapEx Coverage 6.26× 9.08× 8.87× 7.57× 8.14× 4.74×
Free Cash Flow Per Share $1.33 $1.67 $1.83 $1.28 $1.01 $0.56

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 25.09× 18.86× 22.76× 36.25× 36.94× —
P/FCF 23.97× 13.93× 18.45× 23.60× 28.17× 28.16×
FCF Yield 4.17% 7.18% 5.42% 4.24% 3.55% 3.55%
EV / EBITDA 14.89× 12.18× 17.93× 21.06× 24.25× 21.57×
P/S 0.88× 0.77× 1.37× 1.42× 1.49× 0.93×
P/B 3.77× 2.75× 4.14× 3.95× 4.35× 2.77×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 5.65B 5.00B 4.30B 3.87B 3.44B 3.03B
Revenues — 5.00B 4.30B 3.94B — —
Cost of Goods and Services Sold 4.56B 3.99B 3.32B 3.08B 2.66B 2.35B
Cost of Revenue — 3.45B 2.81B 2.56B — —
Gross Profit 1.09B 1.01B 981.22M 866.92M 779.61M 682.26M
Selling, General and Administrative Expense 682.45M 630.25M 607.43M 566.12M 525.71M 500.20M
Operating Expenses 749.99M 691.16M 666.63M 626.69M 588.76M 571.51M
Operating Income (Loss) 337.91M 321.83M 314.60M 240.23M 190.84M 110.75M
Income Tax Expense (Benefit) 75.31M 71.78M 91.65M 55.21M -23.40M 2.83M
Net Income (Loss) Attributable to Parent 207.59M 211.82M 267.09M 150.56M 139.90M -8.08M
Earnings Per Share, Basic $1.28 $1.23 $1.49 $0.83 $0.78 $-0.04
Weighted Average Number of Shares Outstanding, Basic 162.10M 171.57M 178.97M 181.10M 179.85M 180.97M
Earnings Per Share, Diluted $1.27 $1.23 $1.48 $0.83 $0.77 $-0.04
Weighted Average Number of Shares Outstanding, Diluted 163.37M 172.84M 180.38M 182.07M 181.21M 180.97M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 232.62M 412.56M 343.85M 294.19M 119.42M 99.27M
Assets, Current 1.26B 1.32B 1.09B 994.34M 710.26M 657.01M
Assets 3.46B 3.42B 3.22B 3.11B 2.79B 2.65B
Long-term Debt 1.16B 1.11B 1.06B 1.06B 1.07B 1.12B
Liabilities, Current 829.35M 780.15M 618.31M 565.35M 459.69M 434.02M
Long-term Debt, Excluding Current Maturities 1.15B 1.10B 1.06B 1.06B 1.06B 1.12B
Liabilities 2.13B 2.02B 1.80B 1.73B 1.62B 1.63B
Stockholders' Equity Attributable to Parent 1.33B 1.40B 1.42B 1.39B 1.18B 1.02B
Common Stock, Shares, Outstanding 156.86M 166.26M 174.58M 181.96M 179.93M 179.79M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 258.45M 323.39M 371.30M 267.55M 208.57M 127.39M
Payments to Acquire Property, Plant, and Equipment 41.31M 35.61M 41.87M 35.36M 25.63M 26.88M
Net Cash Provided by (Used in) Investing Activities -161.08M -36.47M -56.51M -108.05M -111.54M -26.33M
Payments for Repurchase of Common Stock 309.95M 252.73M 250.26M 0 0 —
Net Cash Provided by (Used in) Financing Activities -277.31M -218.21M -265.13M 15.27M -76.87M -68.85M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (OPCH CIK 0001014739), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MH

MCGRAW HILL, INC.

TWST

Twist Bioscience Corporation

CTO

CTO REALTY GROWTH, INC.